218 related articles for article (PubMed ID: 22978632)
1. Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells.
Freeman JB; Gray ES; Millward M; Pearce R; Ziman M
J Transl Med; 2012 Sep; 10():192. PubMed ID: 22978632
[TBL] [Abstract][Full Text] [Related]
2. Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
Rapanotti MC; Viguria TMS; Spallone G; Terrinoni A; Rossi P; Costanza G; Campione E; Lombardo P; Pathirannehalage CD; Orlandi A; Bernardini S; Bianchi L
Cancer Treat Res Commun; 2020; 25():100262. PubMed ID: 33338742
[TBL] [Abstract][Full Text] [Related]
3. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
Joshi P; Jacobs B; Derakhshan A; Moore LR; Elson P; Triozzi PL; Borden E; Zborowski M
Oncotarget; 2014 May; 5(9):2450-61. PubMed ID: 24811334
[TBL] [Abstract][Full Text] [Related]
4. Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.
Cools-Lartigue JJ; McCauley CS; Marshall JC; Di Cesare S; Gregoire F; Antecka E; Logan P; Burnier MN
Mol Vis; 2008 Jan; 14():50-5. PubMed ID: 18246031
[TBL] [Abstract][Full Text] [Related]
5. Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.
Rapanotti MC; Campione E; Suarez Viguria TM; Spallone G; Costanza G; Rossi P; Orlandi A; Valenti P; Bernardini S; Bianchi L
Front Mol Biosci; 2020; 7():92. PubMed ID: 32548126
[TBL] [Abstract][Full Text] [Related]
6. Circulating melanoma cells and survival in metastatic melanoma.
Rao C; Bui T; Connelly M; Doyle G; Karydis I; Middleton MR; Clack G; Malone M; Coumans FA; Terstappen LW
Int J Oncol; 2011 Mar; 38(3):755-60. PubMed ID: 21206975
[TBL] [Abstract][Full Text] [Related]
7. Multi-Marker Immunomagnetic Enrichment of Circulating Melanoma Cells.
Beasley AB; Acheampong E; Lin W; Gray ES
Methods Mol Biol; 2021; 2265():213-222. PubMed ID: 33704717
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
[TBL] [Abstract][Full Text] [Related]
9. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells.
Ulmer A; Schmidt-Kittler O; Fischer J; Ellwanger U; Rassner G; Riethmüller G; Fierlbeck G; Klein CA
Clin Cancer Res; 2004 Jan; 10(2):531-7. PubMed ID: 14760074
[TBL] [Abstract][Full Text] [Related]
10. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
[TBL] [Abstract][Full Text] [Related]
11. Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma.
Klinac D; Gray ES; Freeman JB; Reid A; Bowyer S; Millward M; Ziman M
BMC Cancer; 2014 Jun; 14():423. PubMed ID: 24915896
[TBL] [Abstract][Full Text] [Related]
12. Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry.
Edgar RH; Tarhini A; Sander C; Sanders ME; Cook JL; Viator JA
Lasers Surg Med; 2021 Apr; 53(4):578-586. PubMed ID: 32557708
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
[TBL] [Abstract][Full Text] [Related]
14. Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.
Mumford BS; Robertson GP
Mol Diagn Ther; 2014 Apr; 18(2):175-83. PubMed ID: 24297151
[TBL] [Abstract][Full Text] [Related]
15. Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma.
Wang N; Tesfaluul N; Li J; Gao X; Liu S; Yue B
Ann Hematol; 2019 Dec; 98(12):2769-2780. PubMed ID: 31748925
[TBL] [Abstract][Full Text] [Related]
16. Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.
Ruiz C; Li J; Luttgen MS; Kolatkar A; Kendall JT; Flores E; Topp Z; Samlowski WE; McClay E; Bethel K; Ferrone S; Hicks J; Kuhn P
Phys Biol; 2015 Jan; 12(1):016008. PubMed ID: 25574741
[TBL] [Abstract][Full Text] [Related]
17. Isolation of Circulating Melanoma Cells.
Ma J; Frank MH
Methods Mol Biol; 2015 Sep; ():. PubMed ID: 26415609
[TBL] [Abstract][Full Text] [Related]
18. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.
Rapanotti MC; Cugini E; Nuccetelli M; Terrinoni A; Di Raimondo C; Lombardo P; Costanza G; Cosio T; Rossi P; Orlandi A; Campione E; Bernardini S; Blot-Chabaud M; Bianchi L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830300
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.
Rapanotti MC; Campione E; Spallone G; Orlandi A; Bernardini S; Bianchi L
Cell Death Discov; 2017; 3():17005. PubMed ID: 28280601
[TBL] [Abstract][Full Text] [Related]
20. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression.
Reid AL; Millward M; Pearce R; Lee M; Frank MH; Ireland A; Monshizadeh L; Rai T; Heenan P; Medic S; Kumarasinghe P; Ziman M
Br J Dermatol; 2013 Jan; 168(1):85-92. PubMed ID: 23013138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
